Tuesday, July 17, 2018
News

Bristol-Myers Squibb, Syngene International expand ongoing research collaboration

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Bengaluru (Karnataka) [India] | November 14, 2017 12:01:13 AM IST
To undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities, Syngene International, India's contract research organization, has announced that it has expanded its ongoing collaboration with Bristol-Myers Squibb.

The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026.

Syngene and Bristol-Myers Squibb have worked together since 1998. The research campus, known as Biocon BMS Research Center (BBRC), Syngene's first dedicated R&D Center, was established in 2007, which was subsequently renewed through 2020 and now has been further extended through 2026.

It is the largest research and development facility for Bristol-Myers Squibb outside of the United States and plays an integral part within their global research and development network.

Since its inception, BBRC has contributed to the discovery and pre-clinical development of numerous drug candidates for further study, as well as generated data that has led to multiple patent filings around the world.

It has also played a key role in reducing the time and costs associated with advancing new compounds to first-in-human studies for Bristol-Myers Squibb.

As part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq. ft. of laboratory and office space for Bristol-Myers Squibb. This facility will house an additional team of 75 Syngene scientists who will work exclusively in support of Bristol-Myers Squibb.

"We are proud of how the partnership with Syngene and the BBRC has evolved" said Carl Decicco, Ph.D., Head of Discovery, Bristol-Myers Squibb. "At its inception, it was thought that BBRC would be a fast, nimble organization that could partner closely with our R&D organization to accelerate the development of Bristol-Myers Squibb's pipeline and the partnership has exceeded all expectations."

Commenting on the extension of collaboration, Jonathan Hunt, Chief Executive Officer, Syngene International, said, "We are very excited about the potential that this expansion to our collaboration with Bristol-Myers Squibb brings in delivering innovative scientific solutions to address disease globally. We consider our work with Bristol-Myers Squibb to be a "flagship" relationship. They understand and appreciate the exceptional quality of science that is accessible at Syngene, and have been consistently generous in sharing their own expertise to nurture young Indian talent for the betterment of the collaboration and for patients everywhere."

BBRC provides integrated services supporting Discovery, Translational Sciences and Product Development functions for Bristol-Myers Squibb. (ANI)

Watch News Videos

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
 
MORE SCIENCE NEWS
Tree shrews violate mammal rules!...
Cygnus spacecraft leaves ISS after givin...
India successfully test fires BrahMos mi...
Dinosaurs more calorie-conscious than hu...
Astronomers discover rare double asteroi...
Otzi the Iceman's last meal reveals rema...
More...
 
INDIA WORLD ASIA
Saudi Airlines flight from Riyadh to Dha...
Truck carrying illegally extracted sand ...
COMIO X1 note, CI Pro launched in Vizag ...
J&K BJP constitutes new team...
53 people rescued from Vamsadhara River ...
Anti-larva team detects 20 cases in Jala...
More...    
 
 Top Stories
US challenges five WTO members for ... 
Iggy can't date a vegan because she... 
Trump, Putin content with summit de... 
Drew Barrymore is off dating sites... 
Iran's army chief says US seeks ins... 
Jessica Simpson's husband makes her... 
Suspect in killing of Indian studen... 
US judge temporarily halts deportat...